Loading...
Decreased expression of MT1E is a potential biomarker of prostate cancer progression
Differentiation of indolent and aggressive prostate carcinoma (PCa) at the time of diagnosis is currently one of the major challenges. This study aimed at identification of prognostic biomarkers to aid in predicting biochemical recurrence (BCR) of the disease. Microarray-based gene expression profil...
Saved in:
| Published in: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Impact Journals LLC
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5617458/ https://ncbi.nlm.nih.gov/pubmed/28977898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18683 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|